Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Minahasa Membangun Hebat Tbk. (HBAT) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Minahasa Membangun Hebat Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Minahasa Membangun Hebat Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Minahasa Membangun Hebat Tbk. trades at Rp340 (market cap 330.96B, 952.6K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.1× Minahasa Membangun Hebat Tbk.'s market cap, and Minahasa Membangun Hebat Tbk. is more actively traded (952.6K versus 635.5K). Which is the better fit depends on your goals.

HBATLABS
Market Cap
330.96B691.25B
Volume
952.6K635.5K
Lot
9.53K6.36K
Turnover
308.16M110.15M
Average Price
323.49173.33
Value
308.16M110.15M
Indicative Equilibrium Price
340174
Indicative Equilibrium Volume
1.65K50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HBAT
View details
LABS
View details

About Minahasa Membangun Hebat Tbk.

PT Minahasa Membangun Hebat Tbk was established based on Notarial Deed No. 44 datedJanuary 31, 2020 of Dian Fitriana, S.H., M.Kn., a public notary in Bekasi.

Read more on HBAT

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS